Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Todd Werpy, ADM to Keynote Present at Biobased Chemicals Conference on September 16-17 in San Francisco, California - Todd Werpy, Vice President of ADM, will give a keynote presentation “Toward a New Generation of Renewable Fuels and Chemicals” at the 4th Biobased Chemicals: Commercialization & Partnering Conference on September 16-17 in San Francisco, CA
Todd Werpy, ADM to Keynote Present at Biobased Chemicals Conference on September 16-17 in San Francisco, California

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2013/05/23 - Todd Werpy, Vice President of ADM, will give a keynote presentation “Toward a New Generation of Renewable Fuels and Chemicals” at the 4th Biobased Chemicals: Commercialization & Partnering Conference on September 16-17 in San Francisco, CA.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In this presentation, Dr. Todd Werpy will offer an overview of ADM’s biofuel research partnerships, discuss some of the pilot projects under way, and describe the company’s efforts to develop both direct, drop-in replacements for commonly used chemicals as well as novel chemicals made from bio-advantaged molecules.

As one of the world's largest agricultural processors, Archer Daniels Midland Company (ADM) connects the harvest to the home to meet the vital food and energy needs of a growing global population. The same operations that enable ADM to produce hundreds of food ingredients from farmers’ crops also provide it with the scale and expertise to efficiently produce renewable fuels and chemicals. As Vice President of Research & Development at ADM, Dr. Werpy is responsible for overseeing ADM’s efforts to expand its product portfolio and strengthening research partnership with government agencies, academic institutions and corporations. Werpy developed the catalytic technology being commercialized by ADM for the conversion of glycerin and sorbitol to propylene glycol. He holds 20 patents in the area of catalysis and chemical conversion of biomass to chemicals.

The 4th Biobased Chemicals: Commercialization & Partnering Conference will look to examine new supply chain developments and business models being adopted for biobased chemicals products. Topics include novel chemical production platforms, advantageous feedstock, end user applications, consumer products and packaging applications, securing funding and strategic partnerships, trends and challenges in commercial scale up, and what’s hot in venture capital. Renewable chemical companies, biofuel companies and end market consumers will be discussing innovations in the science, technology and end-market development of biobased chemicals, polymers and plastics. Get the latest updates from investment, scientific, manufacturer and business perspectives - the highlights and the challenges to making big new things happen with special emphasis on commercialization!

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Todd Werpy, ADM to Keynote Present at Biobased Chemicals Conference on September 16-17 in San Francisco, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  1Click Games







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today